Main Menu

Dr Amit Sud

Senior Researcher

The alt text
Dr Amit Sud is an Academic Clinical Lecturer in Genetics and Epidemiology at the ICR and is completing his Haematology training at The Royal Marsden hospital. Team: Cancer Genomics
+44 20 8722 4385 ORCID 0000-0002-6133-0164

Biography and research overview

Amit's main research interest is in genetic susceptibility to haematological malignancy and the long-term side effects of cancer therapies. More recently, he has been interested in studying the impact of SARS-CoV-2 on cancer care.

He graduated from the University of Manchester with an Honours in Medicine and a Distinction in Medical Research (Masters).

He completed Foundation Training in Central Manchester University Hospitals NHS Foundation Trust and Core Medical Training in Lewisham Hospital and Guy's and St Thomas' NHS Foundation Trust, London. In 2013 he was awarded a National Institute of Health Research Academic Clinical Fellowship in Haematology in South West London. This led to a Cancer Research UK-funded PhD at the ICR followed by a Visiting Scientist Fellowship at the The German Cancer Research Center (DKFZ), Germany. Following this, he was awarded the National Institute of Health Research Academic Clinical Lectureship at the ICR and is continuing his Haematology Training in South West London (Royal Marsden NHS Foundation Trust, St George's University Hospitals NHS Foundation Trust. Epsom and St Helier University Hospitals NHS Foundation Trust).

Amit became a member of the Royal College of Physicians London in 2012. He was awarded the Royal College of Pathologists Research Medal in Haematology in 2018 and the Royal College of Physicians Turner-Warwick Lecturer Prize in London in 2019.

Amit is a member of of the National Cancer Research Institute Hodgkin lymphoma subgroup. He is co-investigator for the AVENuE trial which is evaluating the use of Avelumab in the frontline treatment of advanced classical Hodgkin lymphoma.